How drug companies are squeezing profits from medications soon to go off patent.
TriCor, smoke and mirrors
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
More in Uncategorized
Past Week
-
A world without antidepressants: What could possibly go wrong?
-
Why no medical malpractice firm responded to my scientific protocol
-
Navigating physician non-competes: a strategy for staying put [PODCAST]
-
When doctors die in silence: Confronting the epidemic of violence against physicians
-
Doctors speak out: Why we’re saying no to burnout
-
Avoiding leadership pitfalls: strategies for success in health care [PODCAST]
-
Past 6 Months
-
Internal Medicine 2025: inspiration at the annual meeting
-
What happened to real care in health care?
-
The silent crisis hurting pain patients and their doctors
-
How to build a culture where physicians feel valued [PODCAST]
-
How the CDC’s opioid rules created a crisis for chronic pain patients
-
Are quotas a solution to physician shortages?
-
Recent Posts
-
Navigating physician non-competes: a strategy for staying put [PODCAST]
-
In the absence of physician mentorship, who will train the next generation of primary care clinicians?
-
Fear of other people’s opinions nearly killed me. Here’s what freed me.
-
What independent and locum tenens doctors need to know about fair market value
-
Health care’s data problem: the real obstacle to AI success
-
What ChatGPT’s tone reveals about our cultural values
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
